IL-33 promotes IL-10 production in macrophages: a role for IL-33 in macrophage foam cell formation

다국어 초록 (Multilingual Abstract)

We evaluated the role of IL-10- in IL-33-mediated cholesterol reduction in macrophage-derived foam cells (MFCs) and the mechanism by which IL-33 upregulates IL-10. Serum IL-33 and IL-10 levels in coronary artery disease patients were measured.
The effects of IL-33 on intra-MFC cholesterol level, IL-10, ABCA1 and CD36 expression, ERK 1/2, Sp1, STAT3 and STAT4 activation, and IL-10 promoter activity were determined. Core sequences were identified using bioinformatic analysis and sitespecific mutagenesis. The serum IL-33 levels positively correlated with those of IL-10. IL-33 decreased cellular cholesterol level and upregulated IL-10 and ABCA1 but had no effect on CD36 expression. siRNA-IL-10 partially abolished cellular cholesterol reduction and ABCA1 elevation by IL-33 but did not reverse the decreased CD36 levels. IL-33 increased IL-10 mRNA production but had little effect on its stability. IL-33 induced ERK 1/2 phosphorylation and increased the luciferase expression driven by the IL-10 promoter, with the highest extent within the − 2000 to − 1752 bp segment of the 5′-flank of the transcription start site; these effects were counteracted by U0126. IL-33 activated Sp1, STAT3 and STAT4, but only the STAT3 binding site was predicted in the above segment. Site-directed mutagenesis of the predicted STAT3-binding sites (CTGCTTCCTGGCAGCAGAA→CTGCCTGGCAGCAGAA) reduced luciferase activity, and a STAT3 inhibitor blocked the regulatory effects of IL-33 on IL-10 expression. Chromatin immunoprecipitation (CHIP) confirmed the STAT3-binding sequences within the − 1997 to − 1700 and − 1091 to − 811 bp locus regions. IL-33 increased IL-10 expression in MFCs via activating ERK 1/2 and STAT3, which subsequently promoted IL-10 transcription and thus contributed to the beneficial effects of IL-33 on MFCs.

참고문헌 (Reference)

1 홍경화, "hMSCs suppress neutrophil-dominant airway inflammation in a murine model of asthma" 생화학분자생물학회 49 : 1-9, 2017

2 Saraiva M, "The regulation of IL-10 production by immune cells" 10 : 170-181, 2010

3 Ma W, "The p38mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharidestimulated human macrophages" 276 : 13664-13674, 2001

4 Liu BS, "TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells" 44 : 2121-2129, 2014

5 Liu G, "Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response" 34 : 1680-1687, 2004

6 Yan L, "SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1" 5 : 1447-1459, 2015

7 Sharma A, "Posttranscriptional regulation of interleukin-10 expression by hsamiR-106a" 106 : 5761-5766, 2009

8 Maroof A, "Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function" 29 : 295-305, 2008

9 Wang Y, "NF-kB activitydependent P-selectin involved in ox-LDL-induced foam cell formation in U937 cell" 411 : 543-548, 2011

10 Xie ZQ, "Molecular mechanisms underlying the cholesterol-lowering effect of Ginkgo biloba extract in hepatocytes : a comparative study with lovastatin" 30 : 1262-1275, 2009

11 Liu Y, "MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation" 585 : 1963-1968, 2011

12 Rosenblat M, "Lysophosphatidylcholine(LPC)attenuates macrophage-mediated oxidation of LDL" 344 : 1271-1277, 2006

13 Chanteux H, "LPS induces IL-10 production by human alveolar macrophages via MAPKinases-and Sp1-dependent mechanisms" 8 : 71-, 2007

14 Kube D, "Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt’s lymphoma cell lines" 7 : 1-7, 1995

15 Brunner SM, "Interleukin-33 prolongs allograft survival during chronic cardiac rejection" 24 : 1027-1039, 2011

16 Miller AM, "Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice" 107 : 650-658, 2010

17 Kurowska-Stolarska M, "Interleukin-33 : a novel mediator with a role in distinct disease pathologies" 269 : 29-35, 2011

18 Mei CL, "Interleukin-10inhibits the down-regulation of ATP binding cassette transporter A1 by tumour necrosis factor-alpha in THP-1 macrophage-derived foam cells" 31 : 1456-1461, 2007

19 Saraiva M, "Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose" 31 : 209-219, 2009

20 Han X, "Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages" 284 : 32950-32958, 2009

21 Yang H, "Interleukin-10 down-regulates oxLDL induced expression of scavenger receptor A and Bak-1 in macrophages derived from THP-1 cells" 512 : 30-37, 2011

22 Schmitz J, "IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptorrelated protein ST2 and induces T helper type 2-associated cytokines" 23 : 479-490, 2005

23 Miller AM, "IL-33 reduces the development of atherosclerosis" 205 : 339-346, 2008

24 McLaren JE, "IL-33 reduces macrophage foam cell formation" 185 : 1222-1229, 2010

25 Sanada S, "IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system" 117 : 1538-1549, 2007

26 Zhao N, "Expression of microRNA-195 is transactivated by Sp1 but inhibited by histone deacetylase 3 in hepatocellular carcinoma cells" 1859 : 933-942, 2016

27 Yao Y, "ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages" 177 : 70-76, 2006

28 Lucas M, "ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus" 175 : 469-477, 2005

29 Rubic T, "Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10" 69 : 527-535, 2006

30 Foey AD, "CD40 ligation induces macrophage IL-10 and TNF-alpha production : differential use of the PI3K and p42/44MAPK-pathways" 16 : 131-142, 2001

31 Yang Z, "Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages" 178 : 1077-1085, 2007